Salona Global Medical Device (TSE:EVMT) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Evome Medical Technologies reported a positive financial performance in the third quarter of 2024, achieving $424,000 in adjusted EBITDA and reducing debt by $1.4 million. The company has also expanded its product offerings by launching a new distribution company and appointing Bill Garbarini as the Chief Operating Officer. These strategic moves are part of Evome’s efforts to stabilize its business and strengthen its market position.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.